current user: public




Query: PF02463.14; SMC_BACSU/2-1172; RecF/RecN/SMC N terminal domain, from PfamA26U

Results of FFAS03 search in PfamA26U
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070    . 1080    . 1090    . 1100    . 1110    . 1120    . 1130    . 1140    . 1150    . 1160    . 1170
# Score Template Links and tools%idFirst FLKRLDVIGFKSFAERISVDFVKGVTAVVGPNGSGKSNITDAIRWVLGEQSARSLRGGKMEDIIFAGSDSRKRLNLAEVTLTLDNDDHFLPIDFHEVSVTRRVYRSGESEFLINNQPCRLKDIIDLFMDSGLGKEAFSIISQGKVEEILSSKAEDRRSIFEEAAGVLKYKTRKKKAENKLFETQDNLNRVEDILHELEGQVEPLKIQASIAKDYLEKKKELEHVEIALTAYDIEELHGKWSTLKEKVQMAKEEELAESSAISAKEAKIEDTRDKIQALDESVDELQQVLLVTSEELEKLEGRKEVLKERKKNAVQNQEQLEEAIVQFQQKETVLKEELSKQEAVFETLQAEVKQLRAQVKEKQQALSLHNENVEEKIEQLKSDYFELLNSQASIRNELQLLDDQMSQSAVTLQRLADNNEKHLQERHDISARKAACETEFARIEQEIHSQVGAYRDMQTKYEQKKRQYEKNESALYQAYQYVQQARSKKDMLETMQGDFSGFYQGVKEVLKAKERLGGIRGAVLELISTEQKYETAIEIALGASAQHVVTDDEQSARKAIQYLKQNSFGRATFLPLSVIRDRQLQSRDAETAARHSSFLGVASELVTFDPAYRSVIQNLLGTVLITEDLKGANELAKLLGHRYRIVTLEGDVVNPGGSMTGGAVKKKNNSLLGRSRELEDVTKRLAEMEEKTALLEQEVKTLKHSIQDMEKKLADLRETGEGLRLKQQDVKGQLYELQVAEKNINTHLELYDQEKSALSESDEERKVRKRKLEEELSAVSEKMKQLEEDIDRLTKQKQTQSSTKESLSNELTELKIAAAKKEQACKGEEDNLARLKKELTETELALKEAKEDLSFLTSEMSSSTSGEEKLEEAAKHKLNDKTKTIELIALRRDQRIKLQHGLDTYERELKEMKRLYKQKTTLLKDEEVKLGRMEVELDNLLQYLREEYSLSFEGAKEKYQLETDPEEARKRVKLIKLAIEELGTVNLGSIDEFERVNERYKFLSEQKEDLTEAKNTLFQVIEEMDEEMTKRFNDTFVQIRSHFDQVFRSLFGGGRAELRLTDPNDLLHSGVEIIAQPPGKKLQNLNLLSGGERALTAIALLFSILKVRPVPFCVLDEVEAALDEANVFRFAQYLKKYSSDTQFIVITHRKGTMEEADVLYGVTMQESGVSKLast
1 -247.000PF02463.14; SMC_BACSU/2-1172; RecF/RecN/SMC N terminal domain  ali  100  1FLKRLDVIGFKSFAERISVDFVKGVTAVVGPNGSGKSNITDAIRWVLGEQSARSLRGGKMEDIIFAGSDSRKRLNLAEVTLTLDNDDHFLPIDFHEVSVTRRVYRSGESEFLINNQPCRLKDIIDLFMDSGLGKEAFSIISQGKVEEILSSKAEDRRSIFEEAAGVLKYKTRKKKAENKLFETQDNLNRVEDILHELEGQVEPLKIQASIAKDYLEKKKELEHVEIALTAYDIEELHGKWSTLKEKVQMAKEEELAESSAISAKEAKIEDTRDKIQALDESVDELQQVLLVTSEELEKLEGRKEVLKERKKNAVQNQEQLEEAIVQFQQKETVLKEELSKQEAVFETLQAEVKQLRAQVKEKQQALSLHNENVEEKIEQLKSDYFELLNSQASIRNELQLLDDQMSQSAVTLQRLADNNEKHLQERHDISARKAACETEFARIEQEIHSQVGAYRDMQTKYEQKKRQYEKNESALYQAYQYVQQARSKKDMLETMQGDFSGFYQGVKEVLKAKERLGGIRGAVLELISTEQKYETAIEIALGASAQHVVTDDEQSARKAIQYLKQNSFGRATFLPLSVIRDRQLQSRDAETAARHSSFLGVASELVTFDPAYRSVIQNLLGTVLITEDLKGANELAKLLGHRYRIVTLEGDVVNPGGSMTGGAVKKKNNSLLGRSRELEDVTKRLAEMEEKTALLEQEVKTLKHSIQDMEKKLADLRETGEGLRLKQQDVKGQLYELQVAEKNINTHLELYDQEKSALSESDEERKVRKRKLEEELSAVSEKMKQLEEDIDRLTKQKQTQSSTKESLSNELTELKIAAAKKEQACKGEEDNLARLKKELTETELALKEAKEDLSFLTSEMSSSTSGEEKLEEAAKHKLNDKTKTIELIALRRDQRIKLQHGLDTYERELKEMKRLYKQKTTLLKDEEVKLGRMEVELDNLLQYLREEYSLSFEGAKEKYQLETDPEEARKRVKLIKLAIEELGTVNLGSIDEFERVNERYKFLSEQKEDLTEAKNTLFQVIEEMDEEMTKRFNDTFVQIRSHFDQVFRSLFGGGRAELRLTDPNDLLHSGVEIIAQPPGKKLQNLNLLSGGERALTAIALLFSILKVRPVPFCVLDEVEAALDEANVFRFAQYLKKYSSDTQFIVITHRKGTMEEADVLYGVTMQESGVSK 1171
2 -47.100PF13514.1; B5J9R5_9RHOB/33-1144; AAA domain  ali follow..  11  1...........................IYGPNEAGKTTTMEAAL-----------------RLFY-GFPLREAYAFKH--------SATFDIEGAARRFTRL--KRIGSLVDETGTALPEAALSAHL--AGLSEGDYR-LDDETIEEIANAQGDIGRLLFSAAAGVADLSGVLDGVRDEANSIRGRTTRIAELKHALADVEKEIREKDVTAGAWKGLKKALTQAQ------YEQAARKSRDVLNISKAQIAGQQRALPLMAE---STLEKSTATYSEYPDQLDFDPERLIELRTDHGTASQNIERLTMEITALKNELDEITLDKEQLELAVQ---DALHDLSVRNRSAQLDLQRRQVEKDVAEEAMSSAALDLGVSPKADLQDLVLSQADISKLETAKEELRDAIASVANESREVADLKKKLEAAGDAVETNTGDTDDSPSISDFDVDRLAPAHAAALQAIGAAKTKARKALSALTFGTVVFEDVPTGVSSMIQAQSWAAEHEKISQTIHNTIDKRDNHQEDLATRIAQGKVLTAGGAVVTDAETEVLLTAREDLWAEHQAALESQ----------------------------------------------------------TASAFYEAMQKHDKA-------------------------MDARVTHASELGQLRQIEQAEVEAQIRLEQADKRLEVLDKELTALDAAVGAATEDAQALFAAREEHQPILDRAEDLRAELSRLLTFEATDVASALTVARQVAEGERKQSENEARAQETLQQAKRNLRKREERHQAALSVEAEARNAWYTLILEMLGDRIAPENLQASLEPLR-ELREHAKTRASAAQRVASMKVDQERFAEEVAALAKAYAETFSALKTLSDRARSAHEAVEKLTGDIKEAEARKSKNSEKLREIKQAIEAIAQQVIEERAALVKLQRTVVSELGVNDIKAAREEMAALSLTDLEAAFENSKSDLERAEE-QVTGDADIATLVEQKATLELQLEDSALEHLELSLGHYLASNSIRRYRDSHRSGMMTATERCFASLTQGAYPSLITQVDKD----AEVLLAVDCTGASKRAAEMSKGTRFQLYLALRAAAHEQTRLPF-FCDDIFETFDEDRTSAACRVMETIGSRGQAIYLTHHRHVVDIAMKVCD.......... 1104
3 -41.400PF13476.1; C4P4D4_ARATH/25-232; AAA domain  ali follow..  21  1...RIRLENFMCH-SNLEIEFGDWVNFITGQNGSGKSAILTALCVAFGCRARGTQRAATLKDFIKTGCSY----ALVYVELKNQGEDAFKPEIYGDTLIIERRISDSTSLTVLKDHSSRKEELRELVEHYNIDVENPVIMSQDKSREFLHSGDKDKFKFFYKATLLQQVDDILQSIGTKLNSANALLDEMEKTIKPIEKEINELLEKIK.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 208
4 -35.400PF12128.3; Q8EAA0_SHEON/1-1188; Protein of unknown function (DUF3584 topsan)  ali follow..  10  16......................NGHTNICGTNASGKTTLQRLVPVFYGEYPSRVVPSTRDS-IIY---EYQKADGLLYQAVLASAGDGK-----------RFIAKGFELSDYIKSQN---AELGRDLKRQGINTREYRAIIQNDRTLLSTGSNRSELRAYARQFALCDGEHSLEKLAKAVHSKEGKMETVKSMIAAIPQRVEAWIRESQLIQGFEVIRPEFEKLEQEF---QLLSAEMRLSSLSRGYRNDESLEADRLEIQQTLSKELDEWKEVRDELNLDLSAAKGDVAKCEYELDAIEDQHGAFLDAAKADLDMLPNWRADMENLSERHKLQTEKHQDIEAAYNARRSKIEQLNRELEGLHSEQDKQREARDKQREVARGDLDALEAQWRSQMDAGKASFSEQEYQFKLNAAELKLRVDGVTYTEEEKLNLAIFDERIHRADEEQESCNAKVERLTSDERKLRAKRDQANEALRIASLRVNERQTALDELHHMLFPQSH-----TLLEFLRKEAQGWEQSLGKVIAPELLHRTDLHPSVTGESDTVFGVNLDLKAIDVPEYAASE-----------------------------------------------------------QELRIRLSKAEE------------------------ALQSAQELQAEAESQLVAINGELDKLSRELTFARTAYKNSRDDLRRLFDEKRSEQDKINKLAERKAFAQQRLTQLDGELKQLKHQHQLWLEEQKEQALEANQLGQIKATIDARRESAKAEQKACETWYKNELKSRGVDEDNILKLKQQIRELETKISRAEQRRSEVLRFDDWYQHTWPKLQTQLSDVKRAASEIDQQLKAKTQEVKTRRQQLETERKASDAAQIEASENLTKLRAVMRKLAELEEAQGSLGERLRQGEDLLLKRDYLMGSVKQYVEHFDSVIASKSGSGLAETWERAREESSINDKGIRLLDYRKLVPQLEQLNVIVPQSIMALREQGRIFGVDLTAFYDVLADIDRRIASQSARITREVGEE--RIRSKISELALDIIGRAALTGGISK--RLKEGNSDLIIR---RQLNESS--SHGMAYLILCKFLLAFTRLGRADVWPIDEL-GTLHHTNVKKIFDAC----GNNNISVLG........................ 1167
5 -31.800PF06470.8; Q0UYB6_PHANO/522-635; SMC proteins Flexible Hinge Domain  ali follow..  25  1...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LPGVHGTIADLLEVPEQYRTVVENAAEGAMFNVVVDDDSVSTKLIDRLIKDKAGRLTFIPLNRIHAPDLN-------LPTRSDMQPLLPKLRYDEQFEDAIRHVFAKIVICPTLDACKSNA....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 114
6 -31.400PF01576.14; O44934_LOLPE/1067-1925; Myosin tail  ali follow..  11  128.......................................................................................................................................................................KNQEATNELGDQIDQLQKVKSRLEKEKTQLRAEMDDVQSQVEHAGK-GCSEKMSKQME------QLSELNAKIDDQARSVSELTSQKSRLQTEAADLTRQLEEAEHNVGQLTKLKSSLGASLEDAKRSLEDEGRLRAKLQAEVRNLNSDIDGIRESLEEEAESKSDLQRALSRANAEVQQWRSKFEARADELEDAKRKLQAKLSEAEQTADTLHSKCAGLEKAKSRLQGELEDLAIDVERSSAHANNLEKKQRNFDKVVSEWQHKCNDLQAELENAQKEARSYSAELFRVRAQCEEVGDTVASLRRENKNLADEIHDLTDQLGEGGRNTHELEKARKHLALEKEEQAALEEAEGALEQEEAKVMRATLEIS-----QIRQEIDRRLQEKEEEFDNTRRN------------------------------------------------------------------------------------------------------------QRAIESMQASLEAEAKGKAEALRIKKKLEGDINELEIALDATNRGKAELEKNVKKYQGQIRELQSQVEEEQAQRDEAKEHYQMAERRCAAINGELEELRTILEQAERARKAAENELADASDRVNELQAQVSTVGSQKRKLEGDVTAMQSDLDELNNELKDADERAKHAMADATRLADELRQEQDHGLSVEKMRKSLESQVKELQVRLDESEAALKGGKKMIQKLESRVRELEAELDSEQRRHAETQKSMRKVDRRVKELSFQQEEDRKNYER---------------QELVDKLQNKIKTYKRQVEEA--------EIAAINLAKFRKVQQELEDAEERADQSEGALQKLRAKNRS............................................................................................................................................. 859
7 -31.400PF10174.4; Q7Q0K7_ANOGA/59-838; RIM-binding protein of the cytomatrix active zone  ali follow..  11  2.............................................................................................................................................KAKLENAQGEQESLKQEMERGQAGIQRIVSERDKAYAELEKIREELERTQATLGKSQLTQEKLQNSLDKAQEIDHLQEKLDKSGGETLQLEKEKINYEFENIQSQLDKSLGQASRIQKEKEAAQMDLDRYRDKADKLQSSLARLQKERDVLSDELEKLKEKSESTQSTALKYQRERDAIQTELEVVKERWEKAHQVHQKLQMERDDATTEIDILKEKLDKALYASQKLIDEKDTEFEKMLEKYDRAQNEIYRLQSRVDTAEADRNRLEVEAERSALAAAKAREDLRKIQEETTRLQEACDRAAMQLGRSKELEDKAKEDVDMIRERLDKCQTDLRRAQSEKDNQQAEIERLTYELDRSHNLYTKQTASLDSAQE---------EIARYGLEIEKMRERYEKTAAELRRLQENESFSREARRMKDE----------------------------------------------------------------------------------------------------------RLREKYDKVIVELENFRGKSQYEQETFDKMKEKFETRENEFQTMELKLHETSLQLDLARAEVTKLISNQDKQRADAERAHIEYEKIRDKHEKLIKEVERLRQNPQSAISPGAATSTVSLADKNELDRLRDRLEKALQSRDATEMEAGRLAKELEKAQLHLTKQQEVYEATRIEFERMSAELTRVLERLEKSEAEKETLRQSTK-IYEKHHQQHASNHHIEQSLMKLEADNKQLMAERDQLVMQLEKSQDMLMSFQQELNAAEVELQRQCEENRR------SSPQQPGSAPAAPQQGQAAAQEIQNYKKEITKLKQMLQETGARGDNELEQWRKVVEQEKNRADQAEKAAIELQKRMQ.............................................................................................................................................. 779
8 -28.700PF05483.7; SYCP1_RAT/28-813; Synaptonemal complex protein 1 (SCP-1)  ali follow..  11  4.....................................................................................................................................................DSNYFKTVNKCTEGDFGVPLTMSSLSKNRENIDTDPAFQKLSILPMLEQVANSGSCHYQEGVNDSDFENSEPMSRLYSKLYKEAEKIKKWKVSIESELKQKENKLQENRKIIEAQRKAIQELQFENEKVSLKLEEEIQENKDLIKENNATRHWCNLLKETCARSAEKTSKYEYEREETRQVYVDLNNNIEKMILAFEELRVQAEEMHFKLKEDHEKIQHLEEEYQKEVNNKENQVSLLLIQSTEKENKMKDLTFLLEESRDKANQLEEKTKLQDENLKELNEKKDHLTSELEDIKMSMQRSMSTQKTLEEDLQIATKTIYQLTEEKEAQMEELNKAKTTHSVVTELKATTCTLEELLRTEQQRLENNE---------------------------------DQLKLITMELQKKSSE--------------------------------------------------------------LEEMTKFKNNKEVELE------------------ELKTILAEDQKLLDEKKQVEKLAEELQGKEQELTFLLQTREKEIHDLEVQVTVTKTSEEHYLKQVEEMKTELEKEKLKNIELTANSDMLLLENKKLVQEASDMVLELKKHQEDIINCKKQEERMLKQIETLEEKEMNLRDELESVRKEFDEVKCKLDKSEENARSIEYEVLKKEKQMKILENKCNNLKKQIENKSKNIEELHQENKALKKKSSAENKQLNAYEIKVNKLELELASTKQKFEEMINNYQKEIEIKKISEEKLLGEVEKAKATVDEAVKLQKEIDLRCQHKIAEMVALMEKDKIVEERDSELGLYKNREQEQSSAKVALETELSNIRNELVSLKKQLEVEKEEKEKLKMEQENTAILTDKK............................................................................................................................................ 786
9 -24.400PF05911.6; Q10P54_ORYSJ/79-939; Plant protein of unknown function (DUF869 topsan)  ali follow..  12  6.........................................................................................................................................................KQHAKVAEEAV------SGWEKAEAEASALKLQLETVTLAKLAAEERAAHLDGALKECKQVRTVKEEGEQKLHDVVFAKTKQWEKIKAEFEAKLLEFEQELIRAGAENDALSRSLEERGDLLMKIDEEKARAEAEIEVLKNTIQSGEREINSLKYEIHVVSKELEIRNEEKNMSVRSADVATKQHMEDVKKISKLEAECQRLRGLVRKKLPGPAALRDYGESRLRRSPAKNSSFHRPMSPMSPVPDYAFENLQHMQKENEFLTARLLSMEDETKMLKEALAKRNSELQTSRNMYAKTAGKLRGLEVQMLTGSQRKSTSNPNMDIHFDGASCTESWANALVSELSHIKKEKGAKSSVTEGSNRLE----LMDDFLEMEKLACLSSEANGHVSTVEKMKIDDTEASLSGITERDGVKDSQSVLALPGTPSNKLQLSDSSPLLKLQSRISSLLDSESPQNNAGNILDSI-----ILKDIEDEADSSNDSKTHHGDMV---------------VADNGSLMKHSSSGSKHAMDQELVNAILKIQDFVKSLDQEVSKFQGQSSDCDGLCDKIQQFSALVEKALSNENVLNDIVMTLSLILSGTSEIKFMMLKENTKEADNNNLDYVDKVTLLENKVQLEPLKDSISGPCLPRSSSDPEIEGPTDSSSEEFEQLKSEKLNLEAELSKCNEVIEETKFRFKELEKSLEELTSKLVASEKSNSLAETQLKCMAESYKSLESRKAELENEIKVLQSKIEVLTAELDDERQNHQEDITRYRDLEEKIERYENERNSMCVDEDADTKAKQEK---------EIAAAAEKLAECQETILIL--------------GRQLQSMRPPAESMGSS.............................................................................................................................................................. 861
10 -23.700PF05557.8; Q9W6G9_XENLA/2-716; Mitotic checkpoint protein  ali follow..  1......................................................................................................................................................................................................................................................................DDSEDNTTVISTLRSFNKFLSQPLEGTAPSLGTSTSTGASLQMQFQQRFLLEDQAAQIRSK-----SNLIQVEREKMQMELSHKRARIELEKAASTNAKNYEREADRNQGLHTRIKALEEKENEFQNKLQEQNEMIKSYKKTIEAQSKKLLEKEDKLSESNENISVLKGKASELQWKIMNQEMQIKTQETEKQELTEQLEIHRKKLQESNEKMQALHELQAQNADNEQKIKSLEQKLSAQEQDAAIVKSMKSDLTKLPKLERELQQLRDE-----------------NAYHREMKENNALLKEE-----------------------------------------------------------VEGLRRAAERFNKMKEDLV------------------GSEIEKEQLVKKLKLWENLEQSTGLNIRTPDDFSRQIMAVQQRELKLKEENMTIQISARMLETSRQQLQEELLKVQSGFLEEKKRREHQEALVRRLQKRVLLLTKERDGMRAILDSYDSELTPTEHS-PQLSRRLKEAEDILQKVQDHNAEMETQLSEALEDAGIQKQKSELLTAELKVLKSQMGSSDQNISFTNEAMSALRLKIEELEAERGRLEEENKILEMRLESLNLQGCYDPSRTKVIHLSLNPASKAKQQRTDTVRHLQEECDKLREIVRILEGGAQIP----------DKLEATGSPQSSQELAELKKQVESA-----------LKNQRLREVFQTKIHEFRTACYMLTGYRIDITTENQYRLTSMYGE..................................................................................................................................... 656
11 -22.200PF13555.1; Q0A6A1_ALHEH/19-80; P-loop containing region of AAA domain  ali follow..  27  1.LQRLEVFNWGTFHDRVSLQPGGDNSLLTGDIGSGKSTLVDAITTLLVPAQRITYNKAAGAE..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 62
12 -21.900PF07111.7; CCHCR_PANPA/27-782; Alpha helical coiled-coil rod protein (HCR)  ali follow..  10  65.................................................................................................................................................AEVIARQLQELRRLEEE---VRLLRETSLQQKMRLEAQAMELEALARAEKAGRAEAEGLRAALAGAEV-KNLEEGSQRELEEVQRLHQEQLSSLTQAHEEALSSLTSKAEGLEKSLSSLETRRAGEAKELAEAQREAELLRKQLSKTQEDLEAQVTLVENLRKHSQTWELERQKLLETMQHLQEDRDSLQATVELLQVRVQSLTHILALQEEELRKCQSLLNRWREKVFALMVQLKAQELEHSDSVKQLKGQVASLQEKVTSQSQEQAILQRSLQDKAAEVEVERMGAKGLQLELSRAQEARRRWQQQTASAEEQLRLVVNAVSSSQIWLETTMAKVEEAAAQLPSLNNRLSYAVRKVHTIRGLIARKLALAQL-----------------------------------------------------------------------------------------------------------------------------------------------ESCPLPPPVADVSLELQQLREERNRLDAELQLSARLIQEVGRAREQGEAERQQLSKVAQQLERELQQTQESLASLGLQLEVARQGQQESTEEAASLRQELTQQQELYGQALQE-TRLREQLSDTERRLNEARREHAKAVVSLRQIQRRAAQEKERSQELRLQEEARKEEGQRLARRLQELERDKNLMLATLQQEGLLSRYKQQRLTVLPSLLDKKKSVVSSPRPPECSASAPIAAAVPTRESIKGSLSVLLDDLQGLSEAISKEEAVCQGDNLDRCSSSNPQMSS................................................................................................................................................................................................................................ 756
13 -20.700PF05622.7; HOOK3_HUMAN/5-718; HOOK protein  ali follow..  11  20..................................................................................................................................................................................NVDAPCQTVEDLTNVMAQVLQKIDPAYFDENWLNRIKTEVGDNWRLKISNLKKILKGILDYNHEILGQQINDFTLPDVNLIGEHSDAAELGRMLQLILGCAVNCEQKQEYIQAIMMMEESVQHVVMTAIQELMSKESPVSAGNDAYVDLDRQLKKTTEELNEALSAKEEIAQRCHELDMQVAALQEEKSSLLAE--------NQVLMERLNQSDSIEDPNSPAGRRHLQLQTQLEQLQEETFRLEAAKDDYRIRCEELEKEISELRQQNDELTTLADEAQSLKDEID-VLRHSSDKVSKLEGQVESYKKKLEDLGDLRRQVK------------------------------------------------------------------------------------------------------------------------------------------------------------------LLEEKNTMYMQNTVSLEEELRKANAARSQLETYKRQVVELQNRLSEESKKADKLDFEYKRLKEKVDSLQKEKDRLRTERDSLKETIEELRCVQAQEGQLTTQGLMPLGSQESSDSLAEIVTPEIREKLIRLQHENKMLKLNQEGDNEKIALLQSLLDDANLRKNELETENRLVNQRLLEVQSQVEELQKSLQDQGSKAEDSVLLKKKLEEHLEKLHEANNELQKKRAIIEDLEPRFNNSSLKIEELQEALRKKEEEMKQMEERYKKYLEKAKSVIRTLDPKQNQGAAPEIQALKNQLQEDRLFHSLEKEYEKTKSQREMEEKYNMGMTLHKKAAEDRLASTGSGQSFLARQRQATSSRRSYPGHVQPA............................................................................................................................................. 711
14 -20.600PF09730.4; Q3TBD4_MOUSE/9-723; Microtubule-associated protein Bicaudal-D  ali follow..  11  2.............................................................................................................................................................................QAHTNHKKVAADGESREESLIQESASKEQYYVRKVL------ELQTELKQLR------VLTNTQSENERLTSVAQELKEINQNVEIQRGRLRDDIKEYKFREARLLQDYSELEEENISLQKQVSVLRQEFEGLKHEIKRLEEETEYLNSQLEDAIRLKEISERQLEEALETLKTEREQKNNLRKELSHYMSINDSLQVSLDGLKFSDDTVTAEPNNDAEALVNGFEHSGLVKSSLDNKTSTPRKDGLAPPSPSLVSDLLSELHISEIQKLKQQLVQMEREKVGLLATLQDTQKQLEQARGTLSEQHEKVNRLTENLSALRRLQAGKERQTSLDNEKDRDS-------------------------------------------------------------------------------------------------------------------------------------------------------HEDGDYYEVDINGPEILACKYHVAVAEAGELREQLKALRSTHEAREAQHAEEKGRYEA---EGQALTEKISLLEKASHQDRELLAHLEKELKKVSDVAGETQGSLNVAQDELVTFSEELANLYHHVCMCNNELDYYREGQGKAGRTSPEGRGRRSPVLLPKGLLATEVGRADGGTGDSPSPSSSLPSPLSDPRREPMNIYNLIAIIRDQIKHLQAAVDRTNEQRIASQELGPAVDKDKEALMEEILKLKSLLSTKREQITTLRTVLKANKQTAEVALANLKSKYENEKAMVTE------TMMKLRNELKALKEDAATFSSLRAMFATRCDEYITQLDEMQRQLAAAEDEKKTLNSLLRMAIQQ-KLALTQRLELLE................................................................................................................................... 714
15 -19.900PF04310.7; MUKB_ECOLI/1-227; MukB N-terminal  ali follow..  15  7.FRSLTLINWNGFFART-FDLDELVTTLSGGNGAGKSTTMAAFVTALIPDLTLLHFRNTTEAGATSGSRDKLKAGVCYSMLDTINSRH------QRVVVGVRLQQVAGRDRKVDIKPFAIQGLPMSVQPTQL------VTETLNERQARVLPLNELKDKLEAMEGVFKQFNSITDYHSLMFDLGIIARRLRS--ASDRSKFYRLIEASLYGGISSAITRSLRD.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 219
16 -18.400PF00261.15; Q805C4_TAKRU/12-248; Tropomyosin  ali follow..  10  1...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RKIQTLQQQADDAEDRAQVLQRQLDSERELREKAEGEVAALNRRIQLVEEELDRAQERLAVALQKLEEAEKAADESERGMKVIENRAMKDEEKMEIQEMQLKEAKHIAEEADRKYEEVARKLVILEGELERAEERAELSECKASDLEEELKNVTNNLKSLEAQAEKYSEKEDKYEEEIKILTDKLKEAETRAEFAERTVTKLEKSIDDLEEKLSSAKEENLGMHQVLDQTLLELNSL................................................................................................................................................................................................................................................................... 237
17 -18.300PF07888.6; Q7ZTT2_DANRE/1-545; Calcium binding and coiled-coil domain (CALCOCO1) like  ali follow..  11  46..........................................................................................................................................................................................................................................GWLTVKDYYTFAWALAPEGYQKGADANCSVAFHPSYLPIPGVEEYQFVYVDGRGDVCAISSQFTFAAPRPLDELVTLEKSGEGEEDGDDLLLVVPKALILQNLLEGCQRELHELHKKFEAVNGDVENERQRWKTDRDEFEILRSDMRSQIEQLKTNLRHSTEKTEELERKHKEAQSSSESMSAEFNALLAERAENQQRIKELEQDSATLTQQKQDIEAELERMKERVKKMTIQRRDEETERIDLQLENEQMHADLRTLQERLEA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERSTGALRRDLSELGSLQSHSHAELHQVRLQSAQMSLQLSQANLALREGQ---STWAQERETLRQSAELDKDRVQKLSRELQKKEEWLQEERSEREKLEVELGIEKDCNRELRASLRALQKEQEQHQLEKQELLDHIHVLELRLDTETDAKWAEAAATPICQFAKSYLHRAAYIDSLPSIDEKPLLESSSELSLSALDSEQHNESTEKNPKDNEDDVMQEDLEVQPFSSGIADQMLS.................................................................................................................................................................................................................................................................... 544
18 -18.300PF05701.6; Q9FWW5_ARATH/24-519; Plant protein of unknown function (DUF827 topsan)  ali follow..  2..............................................................................................................................................................................................................................................................APFQSVKAAVSLFGEVAVSKQRSTPRRSRLSSESVCDKETQLMLVHKEFMKIKQKLDNAESTRSRALDDLSKAKKTMEDLSNKLETVNKSKQSAIDTKETVQQREEQLEHDKCHGSPPHHHELDVAREQYISTTVELDAAKQQLNKIRQSFDSAMDFKATALNQAAEAQRALQVNSAKVNELSKEISDMKDAIHQLKLAAAQNLQEHANIVKEKDDLRECYRTAVEEAEKKLLVLRKEYEPEL--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SRTLEAKLLETTSEIEVLREEMKKAHESEMNTVKIITNELNEATMRLQEAADDECSLRSLVNSLRMELEDLRREREELQQKEERLEIEETKKLEALKQESLKLEQMKTEAIEARNEAANMNRKIESLKKETEAAMIAAEEAEKRLELVIREVEEAKSAEEKVREEMKMISQKQESKKQDEESSGSKIKITIQEFESLKRGAGE---TEAAIEKKLATIAAELEEINKRRAEADNKLEANLKAIEEMKQATELAQ.................................................................................................................................................................................................................................................... 496
19 -18.100PF13166.1; Q63PW4_BURPS/9-780; AAA domain  ali follow..  12  119..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EVEIDKLEDELGSVENKTGLRHSYQEK-KKAHADKKKAAQDAQDELDKKIFDKANKNPTGIKHNSLYKDANYDVRKLKLDIKTVQDKKIAPLDDADRSSKVKLLSEVALPDIEKSLPALAKSTVELITKKIKPSAPIQELPLPADLWKRLGDHFNQESQDLEKDLDSVLTKISNEKTRIKNVVTVDRKYSANQATFDNLKADLDDAINNHEKSLQSLEDELNARKKDIFT-ERSTIDVQDNTVSISQKVSLVNELIERNNKTTTSLEEDQKIARNELRLSEISQFTIDIDLAGEEKKIKALEDQITKA--------DELDAVEAEGKKRVDRVKELRTQLRDEKRGAEQVNQYLGHFL---------------------GHGGLSLSAVEEANTATYRFQIL---RGDQAAYNLSEGECSLVAFCYFLAKLEDIETLIIYIDDPISSLDSNHIFFVFSLIENYYRYEQLFISTHN...................... 622
20 -17.100PF04849.8; Q4SVU4_TETNG/101-401; HAP1 N-terminal conserved region  ali follow..  12  1.................................................................................................................................................................................EYICLPSHGGKAKEVEEEEMDEEQQIGRSSMTTKLLWLKFLRV-----------LCADRVGQMTKTYSDIDAVTRLLEEKERDLELAARIGQSLLKKNKALSERNDLLEEQVEHIREEVSQLRHDLSMKDELLQFYTNAAEESEGESFTSTPVRPADSNVSTPTFFPLDSLQKKLKDLEEENKSLRSEASHLETETISYEEKEQQLVHDCVKELRNSNLQITSLSEELARKSDDASRQQEEITHLLSQIVDLQKKVKLHALENEELTQHLGAAKDAQRQLTAELRELEDKYAECMEMLHEAQEELKNLRNK........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 300
21 -16.700PF09738.4; LRRF2_BOVIN/31-326; Double stranded RNA binding protein (DUF2051 topsan)  ali follow..  10  6..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AAKRAARAEARDIRMRELERQQKELDEKSDKQYAENYTRPSSRNSASATTPLSGNSSRRVSGDTSSLIDPDTSLSELRESLSEVEEKYKKAMVSNAQLDNEKNNLIYQVDTLKDVIEEQEEQMAEFYRENEEKSKELERQKHMCSVLQHKMDELKEGLRQRDELIEKHGLVIIPDGTPNGDVHQEPAVGAITVVSQEAAQVLESAGEGPLDVRLRKLAGEKEELLSQIRKLKLQLEEERQKCSGRDGTAGDLAELQNGSDLQLIEMQRDANRQ-----------------ISEYKFKLSKAEQDITTL............................................................................................................................................................................................. 296
22 -16.200PF08580.5; Q6FY01_CANGA/41-592; Yeast cortical protein KAR9  ali follow..  10  7..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CDVLEWITTQMNRILEIFPQIIDSTGIEVSSLLEYLDWLQERKELLFELVNDINSIGPFLSDILEGIELNTDPNKSLDEHEMHLIDLIERCSTLRDDLDPWLNKLRKLLDATLEFKEISNDHMDGLDKVVSENIQDIQEERFTSPVRHAPSFTLEQIVDLLKQNSDSNAISVPTFNKQEKLISERFLELRRSVPAIEKSLTDILPNRIDNRRDMTNIDSLAEFLRDKYKVLMKKYEFMSSEISELNAELIDKRILFVNLNHEINFILDDY-EKLKKKLNSVEEIGINVQIREKMSHQMTQKSLTIERTFKVIFKAQEF-AGIASKTNEMKNRWEKVRVDDKLLRSVSVDSGPEISS............................................................................................................................................. 373
23 -15.900PF06160.7; EZRA_BACP2/3-562; Septation ring formation regulator, EzrA  ali follow..  13  27.....................................................................................................................................................................IDRLEAWKIEILNRSIVEEISKIKHLKMTGETEQFFERWRAEWDDIVT-PKVEELLYDAEEYSDKYRFSKAKQVLTHIEDLLSAADSNIEDILKEIADLVTSEEQNRKDIEKVKEQYQTVRKNLLAYSHLYGTLYDKMEQDLDEAWEGIKQYEEETEN-----GNYMKARKILLEQDRRLDQLQLYINDVPKLIADCKQTVPGQLTKLKDGYQEMSEKGYKLEH--IQITKELETLNKQLARAEKLLID-ELNLEEASSILQMIDDAIETLYDQLEAEVEAGQEIKSRMPELTEAFEKLEQDHTQTKAETALVKESYKLTAGELDQQKAFEKRLE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------EIEKLMKQIREKLDRDHVAYSLLMDEINQLETFIEDAKALHDTFKGHLQSLRKEELQARETLAELKTMLTDTVRQLHK-----SNIPGVPAEMKERAEKAQEMIHQVHEQLENLPLNMPAVNQQLKEASDTVRNVVDETEEMLSKVDQIERIIQYGNRFRSQNHILSEQLKEAERRFYAY--DYNGSFDIAAAAVEKASPGAVQKLLAQQE................................................................................................................................................................................................................................................................................................ 559
24 -15.200PF09728.4; Q5RIN4_DANRE/94-406; Myosin-like coiled-coil protein  ali follow..  10  3.....................................................................................................................................................................LGKEAASLLQSLNKLGSPEEKVEMVLKKYSELVDEHRTEKKQLEQFQQ------------------RQGLLVKQRDQLQFEHSRAILARSKLETLCRELQRHNRTLKEESLQRLREDEMKRKEITTFQSTLVDIQSQIEQHSNRNNKLCKENSELAGKLKTIIEQYERREESLEKIFKHRDL---QQKLSDAKLEEANMLLTQAEEKHKREKEYLLKEAIDKTKKYCTLREQELQMKKQLVLYSQKFDDFQNTLAKSNEIYVTFKQEMDKMTKKMKKLEKESTTWKTRFESCNKALVEMIDERSEKGKEFELFTLKIDRLETLCRALQD..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 311
25 -15.000PF09787.4; A7USX6_ANOGA/12-516; Golgin subfamily A member 5  ali follow..  13  90.........................................................................................................................................................................ENASYSKPEPSYSIEQELAAIKIVLAEIKAERDELKSELDSTLSQQLSNGETES--------KLLDLEVLCQNLSEEKMALAGKLLSLEEANGKYVKSISELESTIAKHIQSEQELNSKLDMARLETENALTELQQYRVRAHATLQLKEKTIEQLKEQMSGSGRTDSAEQILQIELEQTRQEKANLAEELTSLNDRMKQREAQWMNAEEKLRVTVHALEQNVQRLQQQILLDADKFSVLEDDFKLKQRELASVREDLTSFTLRLHEKESENSKLRNKIHTPVSPLNDQEDRLASLTQSLVQKQTALETVTVERNALRIQLEKLENQYRNTA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 427
26 -14.600PF10168.4; Q707M9_XENLA/4-726; Nuclear pore component  ali follow..  376...................................................................................................................................................LYRDPICPSRYHCTHVAGVHSVG---NRLEKFLSSGEEDKDSLQELAAEQKCLVEHILCTMPLRCRMICITCDFECIARPL-LTTIRPPSPPLLCSQIDKSSTEILPHVLADVKGPFEIHIRGILRRNSANPLLLNSSSKDSSPPPEECLQLRATQVFREEYLLKQDLAKEEIQRRVKLLIAQKEKQLEDVRYCREERKSLTETAEHLAEKFEEAKERQEDLINRLKRILRSFHTQLPVLSESERDMKKELQATTEQLQHLGNCINQVKRKMSYQEKQMEKGKSPR---KSSLTLSDYQKKNIKTVLKEHGEHIQEMVKQINNIRNHVN....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 722
27 -14.600PF10481.4; CENPF_HUMAN/1-288; Cenp-F N-terminal domain  ali follow..  11  19.......................................................................................................................................................................................................................................KIQELEGQLDKLKKEKQQRQFQLDSLEAALQKQKQKVENEKTEGTNLKRENQRLMEICESLEKTKQKISHELQVKESQVNFQEGQLNSGKKQIEKLEQELKRCKSELERSQQAAQSADVSLNPCNTPQKIFTTPLTPSQYYSGSKYEDLKEKYNKEVEERKRLEAEVKALQAKKASQTLPQATMNHRDIARHQASSSVFSWQQEKTPSHLSSNSQRTPIRRDFSAGEQEVTPSRSTLQIGKRDANSSFFDNSSSPHLLDQLKAQNQ.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 288
28 -14.600PF03999.7; PRC1_HUMAN/37-615; Microtubule associated protein (MAP65/ASE1 family)  ali follow..  12  1...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LQRTEVV--KKHIKELLDMMIAEEESLKERLIKSISVCQKELNTLCSELHVEPFQEEGET----TILQLEKDLRTQVELMRKQKKERKQELKLLQEQDQELCEILCDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEALDHTPDTSFE-RDVVCEDEDAFCLSLENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREAVATIMSGSKAKRKALQLEVDRLEEKMQNMKKVIEAIRVELVQYWDQCSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKEL-FEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKE--EKQRAKLQKMLPKLEEELKARIELW......................................................................................................................... 377
29 -14.500PF06008.9; P70570_RAT/237-496; Laminin Domain I  ali follow..  10  2...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LQGLSVNTGSLEQIRHVEMQAKDLRNQLLGFRSAISSHGSQMDGLEKELSHLYQEFETLQEKAQVNSRKAQTLYNNIDTTIQNAKELDMKIKNILTNVHILLKQIARPGGEGMDLPVGDWSRESAEAQRMLRELRGRDFKKHLQEAEAQKMEAQLLLNRIRTWLESHQVENNGLLKNIRDSLNDYEAKLQDLRSVLQEAAAQGKQATGLNHENEGVLGAIQRQMKEMDSLKKYLTEHLATADASLLQTNSLLQRMD.................................................................................................................................................................................................................................................... 257
30 -14.200PF09789.4; Q16UI1_AEDAE/24-343; Uncharacterized coiled-coil protein (DUF2353 topsan)  ali follow..  11  1..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HRKLQSKVEALKIMRNELEKYRSERDQFKLMAETLQMRYSAMKSSLNSPEFQAAGFG-HSSAVSLLVNQTRERNISLSTEVEALRQRVHELEGDIDVLRTKNFDLQAAFNKMKSTEETKLRDRKVWDEEKSKLIAQMETLKKKNAQLQYDVRSLLDEKEDVVMERDAYKCKAHRLNHELSVMLKGDQSQQK-----IVDVDGLILENKYQQEKITNLENELELSRQSATKYKNMLDTKRKKGIIKLGTNNNQRVMSHSQVKDLLE--------------------------RGTVEELPLKAATISELKSLCLALLDNVNDKSLALSHQKKTNKLLAAKITELEQRILAL................................................................................................................................................... 320
31 -14.000PF06818.10; Q4RYH9_TETNG/478-682; Fez1  ali follow..  10  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KWEVCQKSGEISLLKQQLKEVQGELAQRVGEIVSLRGQLRETRGELTNTQVLLQEAHGTTRTRTLELEVCENELQRRKSEAELLREKAGRLEAELAHLKDALASQGPGNRQCQVFPEDQEQLLA--RAQEPSGGEVLQNMSVKMDRMRAELSYEHQRAEQQMSSFEEERRIWQEEKDKVIRYQKQLQQNYVQMYRRNRELEQLLQE................................................................................................................................................................................................................................................................................................... 205
32 -14.000PF12795.2; Q3KJ67_PSEPF/35-273; Mechanosensitive ion channel porin domain  ali follow..  11  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SLDKLTDSKLPEADKKALQTVLQNTLNQLNNRRDYEQKLIDLKQQLATAPKQTIENSRELTRLKASAVVPVAQRFP-KENIQQLEQMLTERSTQQSDLQKALADANSLIITAQTRPERAQAEISSSQTRIQQINNILKTGKDAGKTVAEQRDLLNAELAALNALIPLRRQELAGNNQLQDLGNSQHDLLSEKSDRLDREIQELQTLINQKRLTLSQETVTQQSIEAQKSGSSALLAT.................................................................................................................................................................................................................................................................... 238
33 -13.900PF04582.7; Q9DPB5_9REOV/1-326; Reovirus sigma C capsid protein  ali follow..  11  6..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PLQRREVVSLILSLTSSTTTNPGDLTAVYERLTNLEASTKSLRQSLSSIVSDLSDVSVDLQDTTRALDDAIATLKGLNTTVAALQNSVASLSSTVNGLTDISSAHSEALSFLRTTIDGNTVAISNLKGDVSTNGLNIADLQNRMKSLESSTSHGLSFSPPLSVADGVVSLDMDPYFCSQRVSLTSYSMAKGTSGSSDVIDMTVNAHCHGRRTDYMMSSTGGLTVTSNAVSLTFSLDYITNMPSDLSRLIPSVGFQAASFPVDVSFTRDSATHSYQV............................................................................................................................................................................................................................. 291
34 -13.500PF04094.9; Q8S5S8_ORYSJ/246-1073; Protein of unknown function (DUF390 topsan)  ali follow..  13  379................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TNTTVLDGLSAQMEVLQAERAELDAAWARVEEGRRSVEAMVEAGRKAHRRHTSELEARRRDLAEIAREVEEERETALIATTVLNEARDDLRQYGSRAAELEKKLDAARGVLDAAAARERRAAENEAASRQREEALEARATALEERARAKERDMADREAAVAIREATLAAHEAACAEEESALRLREDTLTERGRALEEAEAAAQRLADSLFLREAAREEARRNLEGARAKRAALDQRVAELEARAKELDARAHGAAVGDGDLAARLAAAEHSIAEL--------------QGALDSSAGEVEALRLAGEVGPGMLRDAVSRLDRAGRQAGLWGGRCAKYAANQGGLAQRLSEMAGTLQRLPEELEETIKS.................................................................................................................................. 737
35 -13.000PF05667.6; CCD22_AEDAE/1-554; Protein of unknown function (DUF812 topsan)  ali follow..  12  250................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SKGGTKHRLAEPSGAAASSGTTEKVVLNNITVETKPGKTPLESLQEEIDALQQEIVQHSEEGVQLESSRKETDESIEEYRKTIVRLKEEKKIKERTHILLEDPEVNVKKLEAIIAAGGERMKKLQDQWDAHRIPLVDTLEAYRLKNSDKLSKSQQVLDQIESTRQKCEEVVIDLQTKGAMYARLQKEFEKLNKTVSRTASRILEIIGNIRKQKNGIDQILQDTRSLQKEINNITGQLDRQFTVTDDLIFRNAKKDEHSKRAYKLLVTLHSDCEE------------IKLVQETGAIKREVRDLEDQIENEKGRN......................................................................................................................................................................................... 554
36 -12.800PF08614.6; A16L1_PONAB/13-207; Autophagy protein 16 (ATG16)  ali follow..  10  2.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KRHISEQLRRRDRLQRQAFEEIILQYNKLLEKSDLHSVLAQKLQAEKHDVPNRHEISPGHDTWNDSQLQEMAQLRIKHQEELTELHKKRGELAQLVIDLNNQMQRKDREMQMNEAKIAECLQTISDLETECLDLRTKLCDLERANQTLKDEYDALQITFTALEGKLRKTTEENQELVTRWMAEKAQEANRLNA................................................................................................................................................................................................................................................................................................................. 195
37 -12.700PF13779.1; A9D7X3_9RHIZ/37-855; Domain of unknown function (DUF4175 topsan)  ali follow..  473....................................................................................................................................................LSLAERRLRDAQNALAEALENGATDEEIAQLMDELREAMQEFLQELARQNQNNPASEMQQAMPEN-RDLDNMLDQIENLARSGARDQAQQMLQELQRMMNNLQAGRQQRQQQQGGPMRQQMDKLGELMRQQQQLMDETMRADRDRQSQSGEGRDRQEQGQNQPGQGQDQGQQGQGSQSLEEMLGALGRSQQELQDALGQLQRDLEGMGINPSEGFGEAGEAMGDAAGNLQQGQTG-----QALGDQGRALQALRQGAEDMMNQMMQAMGNQQGDAEGEGPDQNGNRSADDRDPLGRPRATTGPDFGSRVQVPDEIDIQRAREILDAIRKRLGDQLSPEVEKRYLERLLD.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 819
38 -12.700PF04108.7; ATG17_PICAN/6-396; Autophagy protein Apg17  ali follow..  4..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VADARANLAHAEQVCNDANMYLTSTSEKLRRREMKVPKLIYYLDALKQQLRLLEIIRDSLVLNLNGVMEKRAALQSQLLKDVDRLHQTIDTLKNTVVVFDGQTTLYEYISESGVEELFNGVSQNLKDIQTLIKGNRTDALLIRLTSDLDHLSNELNALDSKFRDMRDPISKLLEINAELEHDMVAILTSFNNHYDQCEKGEAILKDPAVPQDEKDELVSVLQNDVEELPEAQRSLTSNAEIIKKNCKEVMKILDIFEDYFQRVETYVCELQEYGESKLRVQLKEFSDINTELEIAQTHQDELVQYNSDFQQFVRSYYSLILELDRRMRVNEHISSAIDNFRSTISNIVE-----DHEKRMEFLQKHGD..................................................................................................................................... 380
39 -12.700PF14073.1; CEP57_HUMAN/68-245; Centrosome localisation domain of Cep57  ali follow..  11  1................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AIFSALKNLQDKIRRLELERIQAEESVKTLSRETIEYKKVL---DEQIQERENSKNEESKHNQELTSQLLAAENKCNLLEKQLEYMRNMIKHAEMERTSVLEKQVSLERERQHDQTHVQSQLEKLDLLEQEYNKLTTMQALAEKKMQELEAKLHEEEQERKRMQAKAAELQTGLETNRLIF.............................................................................................................................................................................................................................................................................................................................. 178
40 -12.500PF05276.9; Q4SIQ7_TETNG/16-252; SH3 domain-binding protein 5 (SH3BP5)  ali follow..  1....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EEEEVDPRIQGELEKLNQSTDDINRWESELEDGRQRFRAVLVEAMCKLDGLMKRIGRAVDDSKPYWEARKVAKQAQIEAQKATQEFQRSVEILRAAKETIALAEERLLEEDSR-SAWQEMLNHATQRVMEAEQSRTRSEAEHKKTAANYNSSISHMRQLEKKLKRSINKSRPYFELKGKYYLQLEHLKILVNERQAKLMSAKAEYRKALRNLESISEEIHAQRRSVAMGTRE....................................................................................................................................................................................................................................................................... 234
41 -12.500PF09726.4; Q4SIM5_TETNG/2-648; Transmembrane protein  ali follow..  13  13YLKFLVVWVLVLLAD-LEFRFE-----YLWP-------------WLFIRSVYDSFRYQGLSDIIFAASTTERGVCLPTVSLWI----------YIEAAI-------------------RFKDLKNFHVD------GYPVVTLG-----------GFKSYVSYKMRLRKQKEVQKENEFYMQLLQQALPPEQQMLQRPEKETEEVTKGISEVEP------------------SVTSQNGAPPGKKSSTLQLPELEYREKAKDSTGKEGKKVGINNNSIIHLDSKLQEAEYIENYAGAKRLNNDLAGENTDSNTHSTSKEEMAGTGKNFKYNSGGGANISNSSPRNHSSSNGSVLSGSTSKNEKKQK-GAGKAQKDPVENCIPNNQLGKPDALVRLEQDVKRLKTDLQANRQLESELRSQLSSLSSQDRSLRSELGPVRQDNELLQNKLHSAVQAKQKDKQTISQLEKRLKAEQEARTLAEKQLAEERKRKKMEEATAAR-----------------------------------------------------------------------------------------------------------------------------------------------------------------------AVALAAATRVESTDSLRSRIRDLETECKKLTMDMKLKEEQIRDLEGKCQELRKY-KENEKDTEVLMSALSAMQEKTQHLENSLSAETRIKLDLFSALGDAKRQLEIAQGQIHQREQEIAELKQKIAEVMAVMPSLSYSSDGSNLSPVTPHYSSKFMDNSPSSLDPNASVYQP.............................................................................................................................................................................................................................................................................................................................................. 646
42 -12.400PF00769.14; MOEH_DROME/332-578; Ezrin/radixin/moesin family  ali follow..  12  1......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ERAEKKQQEYEDRLKQMQEDMERSQRDLLEAQDMIRRLEEQLKQLQAAKDELELRQKELQAMLQRLEEAKNMEAVEKLKLEEEIMAKQMEVQRIQDEVNAKDEETKRLQDEVEDARRKQVIAAEAAAALLAASTTPQHHHVAEDENENEEELTNGDAGGD----VSRDLDTDEHIKDPIEDRRTLAERNERLHDQLKALKQDLAQSRDETKETANDKIHRENVRQGRDKYKTLREIRKGNTKRRVDQFE.................................................................................................................................................................................................................................................... 245
43 -12.400PF03082.9; MS2A_DROME/1-264; Male accessory gland secretory protein  ali follow..  10  16..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TVASCDSEQQLDSAMHLKSDSTKSASLKNVAPKNDET--QAKIAKDDVALKDAKKGDYIMDIDISDLPLDDYPINRSKSLKSSSIDLNNIPFNKGLDDFPAKEKNQGSNQSALKALQQRLLTEQNNSLLLRNHSIYLMKEIEARKTDIIKVRQLNLDLELELNTVNRRLLELNGQLQNTRKSTKPCKKR--SSKDSAPPAANQFQEANVRNTYRNKYLTLLKELSQKINNEIAKVATDVPTETNPSQG............................................................................................................................................................................................................................................................. 259
44 -12.200PF07902.6; Q1CPP5_STRPB/1-621; gp58-like protein  ali follow..  1...................................................................................................................................MSRDPTLLIDE---SNLTIGSDGRAYYTFKADGDTKSVKLANNKCIGTTRFNQLMIERGGKPTNYVAPVVVEGSGETGLFKNLEGALSQLKELNLELTDTVNSQLWAKIKLTTNGMLREYHRDNITTEIVESANGIATRISE---DTDKKLALINETVSGIRRDYQDADRQLS--STYQAGINGLKATMANDKNDLKAVIQATAQGLQKYDDEIQQLSAKITTTSSGTTEAESKLADLRAEFTRSHQGMRTVLESRISGLSTQQSTAYQISQEIKNREGAVSRVQQDLASYQRRLQDTEKNYSSLTQTVRGLQSTVSAPNRGLESRVTQLAGLIEQKVTRGEMESYIRGAGDSIMLAIK......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 355
45 -12.200PF10473.4; Q9GKN4_CANFA/3-142; Leucine-rich repeats of kinetochore protein Cenp-F/LEK1  ali follow..  17  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EKKQLHVLEKLRESERKADALQDKIENLERELQMSEENQELVILDAENSKAEVETLKTQMELTTKSLKDLESDLVTVRFEKENLIKQLQDKQGQVSELDTLLSSFKGQLEEKEREKIEMKEESRAALEMLRTQLKELNE...................................................................................................................................................................................................................................................................................................................................................................... 140
46 -12.100PF03904.8; YP2A_STAAU/1-230; Domain of unknown function (DUF334 topsan)  ali follow..  2....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RKGQLIMSMKDIKNNKENPNTQMNSKSTGTPSSSTQNSLNNEELSELKRQNKLIVKYLAEIQENQKIREKEQKEITSELKEATKDFRDKSLKIRNDFVDVLQEKLKHVDTEELKDILGRGIYKVREENDRMLQEVKRSHEHYQTRQKYLFTGIGAMLLVFMLFALIMTIGSDFMS................................................................................................................................................................................................................................................................................................................................ 176
47 -12.000PF01496.14; VATM_DICDI/30-807; V-type ATPase 116kDa subunit family  ali follow..  10  11....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QFLDDNEHVNLFQRNFVNEVKRCDDMEKKLKFFEDQVKKEPKLLPDNMLSVVDDDSQMDELEGRFDELESELKQVNANQETLQRNYN----ELIQLRHVLTKDSVFFQENPNLIEGEGHEHSARSPLLAEDQHVSEVAKQGVKLGFITGVMNTDKMPQFQRSLWRTRGNNYVKDARIEEEIIDPQTGEETAKTVFIVFFQGERLQQKIKKICESFGANIYDCPDNSFERSNLLQKVTVRITDLYEVLQRSKDHKRQTLAGIVPRLYSWKKKVLLEKSIYHTMNLFDYDVGR-KDKIEEIQLALRTATTRSGALVPSVLSIIKTEG-THFETNKYTSSFQEIVNAYREVNPAV----------TIVTFPFLFGVMFGDGHGALLLL-------SALGLISLEKKLAGKKLNELIQMPFDGRYVLFLMSLFSI................................................................ 442
48 -11.800PF09755.4; A0AUQ3_DANRE/3-319; Uncharacterized conserved protein H4 (DUF2046 topsan)  ali follow..  10  1...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ADSASESDTDGATPHCSSSSSSSILISSFRLEELSNRLASLQQENKVLKIELETFKLKCKALQEENRDLRKASVTIQARAEQEEEFINTLFKKIQALQKEKETLAVNYEKEEEFLNELSRKLMQLQHEKAELEQHLEQ------EQEFQVNKLMKKIKKLENDTISKQLTLEQLRREKIDLENTLEQEQEALNRLWKRMDKLEAEKRILQEKLDQPVSAPPSPRDTISMEIDSPENMMRHIRFLKSEVERLKKNLRTSELQHTEKRAQY------------------------IEEERHMREENIRL--------RKLQREVERREALCRQLSESESSLEMDDERYFN.................................................................................................................................................... 314
49 -11.700PF10234.4; A7SE98_NEMVE/14-284; Clusterin-associated protein-1  ali follow..  22.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VAEVLIWLVKRYDPNVELPMDVETEQDRVLFIKAVAQFMATKAHNTKKLYGADGYAVKELLKVTSVLYNAMKSNVTDDEAEPSDVTSLTFDISSRISDLKASRQLASEITTALYDLLGHEVELRDIRTRAIAKPLEVNELENGIKKSISLAQDDIRKTTQMLDNIASDEANLEAKIDKKKQELERNQKRLRSLESVRPAFMDEYEKLEEELKKVYETYMEKHRNLSYMEQLLDDVNRAEQDRFE.......................................................................................................................................................................................................................................................... 271
50 -11.600PF06637.6; PLVAP_HUMAN/1-442; PV-1 protein (PLVAP)  ali follow..  12  55................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................STESNLQATERRAEGLYSQLLGLTASQSNLTKELNFTTRAKDAIMQMWLNARRDLDRINASFRQCQGDRVIYTNNQRYMAAIILSEKQCRDQFKDMNKSCDALLFMLNQKVKTLEVEIAKCTKDKESVLLNKRVAEEQLVECVKTRELQHQERQLAKEQLQKVQADKDKFEMDLRNLWRDSIIPRSLDNLGYNLYHPLGSELASIRRACDHMPSLMSKVEELARSLRADIERVARENSDLQRQKLEAQQGLRASQEAKQKVEKEAQAREAKLQAECSRQTQLALE------EKAVLRKERDNLAKELEEK--------REAEQLRMELAIRNSALDTCIKTKSQPMMPVSRPMGPVPN............................................................................................................................................. 409
51 -11.400PF07058.6; MP704_ARATH/209-559; Myosin II heavy chain-like  ali follow..  10  2.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VDDLQNKNQELMKQIEICQEENRIIDKMHRQKVAEVEKLMQSVRELE----EAVLAGGAAANAVRDYQRKFQEMNEERKILERELARAKVNANRVATVVANEWKDSNDKVMPVRQWLEERRFLQGEMQQLRDKLAIADRAAKSEAQLKEKFLLRLRVLEESLKGPTSSSSRGTSVGRSSSNGPTRRQSLGGAETSPKITSNGSLIKRTPS-SQLRSLTASASTVLKHAKGTSRSFDGGTRSLDRSKVLINGPRSNFPLNHKSSEGTSRGESPSSIKGEEESADKATNNDSVPGVLDLLQKEVITLRKAAHEKDQSLRDKDEAIEMLAKKVETLTKAMDVEAKKMRREVAVMGKE............................................................................................................................................ 351
52 -11.300PF10498.4; IFT57_XENTR/25-384; Intra-flagellar transport protein 57  ali follow..  33....................................................................................................................................................LPTNPGEQFYMFCTLA-LISKAGHHFDQPQEYDDPNATISNILSELRSFGYSVDFPPSRLKAGYG-EQVCYVLDCFAEEVLKHIHFSWKRPTYPTEEQDEENVIEDDAELTLNKIEDEIAEEDSDNDQEHFIDLNALSAQTQKLNTKESSKPEEILESNTDAAEWILEVERVLPQLKTIRTDNKDWRVHVDQMHQHRDGIDTSLKETKGYLDKLHNEVAKALEKVSSREKYINNQLEQLVQEYRSVQAQLSEAKERYQQASGGVTERTRILAEITEELEKVKQEMEEKGSSMTD-GAPLVKIKQALTKLKHEIVQMDIRTGVVEHTL........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 359
53 -11.300PF05010.9; Q2NKK4_HUMAN/638-837; Transforming acidic coiled-coil-containing protein (TACC)  ali follow..  12  1..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QYSQKDLDAVVKATQEENRELRSRCEELHGKNLELGKIMDRFEEVVYQAM---EEVQKQKELSKAEIQKVLKEKDQLTTDLNSMEKSFSDLFKRFEKQKEVIEGYRKNEESLKKCVEDYLARITQEGQRYQALKAHAEELQLANEEIAQVRSKAQAEALALQASLRKEQMRIQSLEKTVEQKTKENEELTRICDDLISKMEK....................................................................................................................................................................................................................................................................................................... 200
54 -11.300PF13870.1; B4J5C0_DROGR/499-675; Domain of unknown function (DUF4201 topsan)  ali follow..  1.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MSQKRNEISDDRLYLISRKHTLGRITDKITKLEQINEDLCDDFINIQNQVAALDKKIEERNNDLKKLRLNYHTELHLTQHNREKALALDSKLDVAKLNLEIMQKKQDQLRECLYKAKLERSNIRKVHSDLSFQGGLLSMP--ALMFDYDETVERVRAKQASVKELKETFKHITQRILE............................................................................................................................................................................................................................................................................................................................ 177
55 -11.200PF01540.11; O53101_MYCHO/1-353; Adhesin lipoprotein  ali follow..  1.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MKKSKNIFITLCGIAATAILPVATISCNDDKLAEKNGKEKADAALKQANALVEELKKNPDYSKILETLNKEIAEATKSFKEAGSYGDYPAIISKLSAAVENAKNEKKAIDDKNAQIAKELAERNAKIQSNIEELKKINNEAFELSKTVNKTIAEVEKKFKIEASFKEQLENFADDLLDKSRQIDEFTTVTSQEGFTLAELESFKEITTTWFNGMKSEWARVLDAWKNELTEINSIIKGVEELKKLSHEISEFSNSVKKTISELEKKFKID-----------------DKTNKDEAKQFKNELENF--------DQLLNKSHEIDKFVTVTSAREDFSLSELESFKSFNTTWFNEMKCEWARVQEAWKDQLKEI......................................................................................................................... 350
56 -11.100PF06785.6; Q5L4N7_CHLAB/1-401; Uncharacterised protein family (UPF0242 topsan)  ali follow..  11  4...................................................................................................................................................................................VKKIFHPIARYHNYLFPIVAFLLPLVCLPFLSNSQKKYSYFVFSII------------SLVGWFFSIGLREKQLKTAAGQLLQTKIRKIIEKDEGLRKICESVEERQYESQQLRSQNQKLLNQLLHVRGVFMKTKSDMQKLEGLVAHLREENQCLQLQLDALSQECREKEEESRELNRELAEALAYQQVLNEEYQATFTEQHNMLDVRQVYIGKLESKVQDLMCEIRNLLQLESNIVENLPR--HAIATSQELPKQLLSELKKIAFKMENIEAASSLTASRYIRSESSVYNYSLECRQLFDNLREENLGMLFVYAPQSQ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 308
57 -11.100PF05335.8; Q8T4I3_DROME/75-260; Protein of unknown function (DUF745 topsan)  ali follow..  3.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LSQKNAKSKASSIAIKAAQDAKAANDAQMAAGEAASLQVKQDLAEKAVQARAAEAALAGKQQIMEQLELEEKEAVAVVDEVKNSLHSTQVNAESAMLAFSEAKIQLDQLKVLLAEATAQMTNIETFANGAQLEMDEKGQLLEAANRRVESISRQVVAARQDYDKTKKAAYKAACAAVEAKQK........................................................................................................................................................................................................................................................................................................................ 185
58 -10.900PF11398.3; Q6D3T4_ERWCT/1-377; Protein of unknown function (DUF2813 topsan)  ali follow..  21  2HLESIEILGFRGINR-LSLTL-DENNVLIGENAWGKSSLLDALSLLLAPTLPLY----DMQDFHFTPGDENSREKHLQIIFTFCETA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 84
59 -10.600PF05384.6; A4J6C1_DESRM/9-167; Sensor protein DegS  ali follow..  5..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KETISVIEKSKEQIYYIAESAHLEWQRVENEIKQTKYQLGKIIDEVNKLEIEERRARVRLMEVSRDFDRYEAAIKQAYEQAQVTQLRLVMLREEEKTLRFKRDHLEISLKRMKDTADRAEKLVSQVGVALQYLSKDLSGVSEKLTNLHDMQQ......................................................................................................................................................................................................................................................................................................................................................... 157
60 -10.600PF03148.9; A7SG13_NEMVE/17-399; Tektin family  ali follow..  52.....................................................................................................................................................................IDDINDWKRSLERCLAETDNEIALLTREKERTERALEAKKVPLDITLECLMLRENRQSIDL--------VRDEVEAQLHKEVEVIEGTKALLQQKVDESFEQLCLLQEARHQLHLDITDKFTTLQIDGDCYAMNNMSTNIYQVNPTRTVKGSVTPETWDSFSNYNKLRAEAEMKASKHLREAIFATLQQTANDLEAQEYSFRKRIHETDQAKSELEWQQKNTMKEIATLEDDIKGLKEAIDAKNAPMMVAQTRLENRTYRPNCRDQPQYQLCHEVAEIAGSMRALTEKLREAQNSLEALRSNLSRINEDLAFKNNSLALDNRCMSVREKMRE.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 383
61 -10.500PF12718.2; A6R7T4_AJECN/7-149; Tropomyosin like  ali follow..  16  1....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KMNTLRLEADDAHAKVEELQNKVKALEQENLAKEQEIKSLTHRNQLLEADVEKLEADLKDAKASASENAQQNESLQRRLQLLEEEAEETDKTLRETNEKLRQTDVKAGHYERKVQALETSRDQWEAKYEQMSKKYEDLQ.................................................................................................................................................................................................................................................................................................................................................................... 142
62 -10.400PF10267.4; Q5RH38_DANRE/59-465; Predicted transmembrane and coiled-coil 2 protein  ali follow..  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RSRFGLDSLQQKILKVKEQLRIEQNLQDENVAEYLKLINCADKQQSGRIK-----QVFEKKNQKTAHNISQLQKKLEQYQRKMKESDISNGTKHATP---KDKDNDNLKETVVTGSGRHPHLDKVKTIGPGVSLSPPFFFSKPREIANLIRNKFGSADNIAHLKSSMETGSGLQAEAGARILSGSATLTP-KPKYPSDDECSTETSVSVESNGQVTGSGTTGQHSGSAREAEVNSRLLEACEEIRELREAQSLLADDIETLKNQFKCEVENITQTLQEERYRCEHLDQLNDLTELHQNETANL--------QELASIEEKMAYQAYERRDIQDALEVCQTRVSKLELQQQQ............................................................................................................................................. 337
63 -10.400PF06120.6; A7MLP6_ENTS8/466-766; Tail length tape measure protein  ali follow..  6...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SVTAVGTRLLGGAMGLIGG----GAGAWYALYQNQEQARQSARDYAGTIEEIRNKTREMSLP--EATDNESKTREALKEQNRLISDQETKIRSIKDAISGYQQMLA---NPGVTINGYMVNHLTSMDEATTELANSTDALAVEQERLSQMQAKSNEIQSVLEGLEHRRVDLIRQQAAEQNKVYQSLLIMNGEHAEFNRLLGLGNNLLAARQGLANIPMRIPQADSTQQQKDALEKSRRDLELSRLKGEAKEIARLGYVADDLGLTTDPQYQNNRQALINIGLETWRNNEANKPQKK........................................................................................................................................................................................................................................ 299
64 -10.300PF13175.1; A9A6W0_METM6/4-391; AAA ATPase domain  ali follow..  22  1.LTKFRIKNYKSIKDSGDVYLSDNITILAGMNESGKTSVLEALEDFNVGKTVRE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 54
65 -10.100PF09074.5; RE107_YEAST/19-214; Mer2  ali follow..  11  28....................................................................................................................................................................................................................................................................................................................................GALEESDKQILEWAGKLELESMELRENSDKLIKVLNENSKTLCKSLNKFNQLLEQDAATNGNVKTLIKDLASQIENQLDKVSTAMLSKGDEKKTKSDSSYRQVLVEEISRYNSKITRHVTNKQHETEKSMRCTQEMLFNVGSQLEDVHKVLLSLSKDMHSLQTRQTALE...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 196
66 -10.100PF10212.4; KRLAQ_CHICK/256-770; Predicted coiled-coil domain-containing protein  ali follow..  11  19.....................................................................................................................................................................................................................................FHTYTEQKAQIFPIDSATDTISPLNQKFSQYLHENAFYVRPLEEGMLQLFESITEDTVTVLETAVKLKAFSEHLASYLCFLRKILPYQLKSLEEECESSLCTAALKARNMELHRDMKRLTAIFEKLHTYVSLLALPSTKPEGLLRTNYSLVFTNIAASLHGSHDILKDISKHYSQKATLEQDVPTATQKLVTTNDCILSSILSLTNGVGKIASFFSNNLDHFTSSLSYGPKGGTEFISPLSAECMLQYKKKAVAYMKSLKKPCADSVPYEE---------------------------------------------------------------------------------------------------------------------------------------------------------------------------LANRRVLLSSTESREGLAQQVQQSLEKIAKLEQEKEHWMLEAQLAKIKLEK---ENQKLKNSLSGHLAETVQERSVLSNTAEQKEETTEKSQREPIKTTSLIGMLTITTDNEKVPDVE-SREDLIKKHYMARIAELTSHLQLADSKSVHFHAECRALAKRLSLAEKSKESLTEELKLASQSISRLQDELMTTK---RSYEDQLSMMSDHLCSMNETLTKQREEIDTLKMTSK............................................................................................................................................................................................................................................................................ 515
67 -10.000PF11180.3; B2JKS0_BURP8/32-221; Protein of unknown function (DUF2968 topsan)  ali follow..  11  5......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VPLTAVGQTIALTPDEAKQSATGNVAELQQMIHG-NDLTELRTTYNGSYGTSLMFRAKDMTYYVALFQQKNFWRVIKTQDEARAEQIYRDFARQTVQLSDVEIRRAKLEAQKAYTDRLVALSQERASRLQADLNIAHEQQTIVNSLQQQTRAEAAALAQQKAQSQEQLRATQRQVRDLQRQLES..................................................................................................................................................................................................................................................................................................................... 187
68 -9.900PF08317.6; Q754X4_ASHGO/431-759; Spc7 kinetochore protein  ali follow..  11  49..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DISTRQIYDALYLQIPLLEIYAFIVKELHRRILDSQRLFQELEEQISNNPPP--YLFRNYFESSDEVKQLMKEQIVLIKSFARLEAKKVWFEWRCQHLKGIKSVLEENLSLVQTEYAEVVARLNEISDIKHRLQALEQSLRHELELLRNGEKPMRVTTLADRLKIEKIKSELKANMIKLNNTANLEEQKEAISADINALRSQIKDVREEISSLKSLVLKNKLHTAHDVSKLRLLFSQMQLF................................................................................................................................................................................................................................................................ 287
69 -9.900PF01601.11; Q7T5V2_CVTKE/550-1208; Coronavirus S2 glycoprotein  ali follow..  7...................................................................................................................................AAMGTSCIYSNGTVLNRLAVTTEYLQTRYQKVT-VCGDFARCRTLLQQYGSFCQSINALSGVNENEDNGLLQYAEAINTGYTLNFTGYNVSNLGGFDLSLVLPKNFTLLQNQGRSTIEDLLFDKVVTLGVSEVDQNYDKCIASRGGSFTNLADLTCAQFYNGVMVLPGVVDPGLMAVYTGSLIGGMALGGITAAASIPFATQIQARVNYLALTQSVLLDNQNLIANSFNKALKGIQSALDTVSKGFDEVARGFESVTVALNKVQDVVNTHSDILNKL---MAQLSVNFGAVSSSLNEIYLKLDQINADAQVDRLITGRLTALSTYVASLQLAAYKADQSRRLALQKVEECVKSQSMRYGFC----------GNGSHVLTIPQSAPNGI--FFIHYTYQPTAYVT-VEAVPGLCVTTPSGKYGECPRLEVALYLDRMSLPHSYEPLSYSEVVNLTSCEANYYNVSESETPFQPALPNFDDEFNDIFTELNTSKDAIKNISSNFNY--------------------------------TIPILNLPDEICRLNHSINTLYNYSDVIDKINQDLNDTFINLE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 577
70 -9.740PF13805.1; C5DXD8_ZYGRC/1-270; Eisosome component PIL1  ali follow..  10  50................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FGPDLARKLSQLVSTEKGVLRSLEVVAYERRAAARQLSLWGVDNDDDVSDVTDKLGVLIFELGELQDQFIDKYDQYRVTLKSIRNIEASVQPTRNRKEKITDEIAHLKYKDPH-SPKIPVLEQELVRAEAESLVAEAQLSNIT------RERMKAAYNYQFDSMRELAEKFALIAGYGKALLELLDDSPVTPGETRSAYDGYDASKQIIMDAEAALESWTLDSAAVK................................................................................................................................................................................................................................................................................ 269
71 -9.620PF13851.1; GAS8_HUMAN/220-420; Growth-arrest specific micro-tubule binding  ali follow..  11  2......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TLMQRHEEAFTDIKNYYNDITLNNLALINSLKEQMEDMRKKEDHLEREMAEVSGQNKRLADPLQKAREEMSEMQKQLANYERDKQILLCTKARLKVREKELKDLQWEHEVLEQRFTKVQQERDELYRKFTAAIQEVQ----------QKTGFKNLVLERKLQALSAAVEKKEVQFNEVLAASNLDPAALTLVSRKLEDVLESKNSTIKDL........................................................................................................................................................................................................................................................................................... 201
72 -9.460PF03429.8; Q9RQF5_ANAMA/1-720; Major surface protein 1B  ali follow..  3.........................................................................................................................................................................................................................................EDDKQQQQNQSDVVQAISAVFQRKSAELQRLNDFIKGADGTLKNVHPHMKSLEALSKQLSEKIAAEAAAKADAKYESVGLRAKAAAALGSLGRLFRSGSKGGYTPQDIDPFMDEAPDTGEKIEVPAGEEQEFGKAAAWGLAGFKRTVDESLEMLDRGMHMLAEGQAQISQGIADKST--ALVREGLETSRLGAGLCRNGLVEASYGVSYANKTMGKYAGKLEKCKNKLDDACHKWHDALNEIESLRTAIDAKAEQQVEGEAWSPEGVSANTFYRGLHKIGAAIAVAAQATWEGLAMTGKFMGAVAKLAGA----------------------------------------VSMCVAAYTAAIAGVILPAGIPLAFMGPESKLAEYV-----AASYLHSNVEQATKDLMASEFAMMTFGGIMT-------CAKLMKGSFAAVNQKFEEINATLAR---EGTDIAQGIKETYKSIGDAFKSVNTGIAKWTTDKWTAALAGYASVEQLEEAKEADRAQAEQRAEAQAMTERVQERAATVAAGTETIKTIVSDMCNELAQICGLSQAERDIPQPPRTTKEIVSQMCNSVKSAFGSISHITNVIRQAGKDAQKIDPQVKVAEISPETIYAMSEALYALNMQESAAINNAL--EAVNDSSKDDQAIVTDLINATIEVCTEQTNTLAGHTAEVQAGLEAAGIKLDDAHTTPE--AKGVEGINPEELAQAAEGLATAVNEASAEGKIQSLNQQESQIAQGGQHAAQQQSSGWSR............................................................................................................................................................................ 720
73 -9.330PF12240.3; B1AXE8_MOUSE/396-605; Angiomotin C terminal  ali follow..  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VDKVEKMQQALVQLQAACEKREQLEHRLRTRLERELESLRIQQRQGNS--QPTNASEYNAAALMELLREKEERILALEADMTKWEQKYLEENVMRHFALDAAATVAAQRDTTVISHSPNTSYDTALEARIQKEEEEILMANKRCLDMEGRIKTLHAQIIEKDAMIKVLQQRSRKEPSKTEQLSSM........................................................................................................................................................................................................................................................................................................................ 184

FFAS is supported by the NIH grant R01-GM087218-01
4 7 2 6 6   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Jaroszewski L, Li W, Godzik A. In search for more accurate alignments in the twilight zone. Protein Sci. 2002 Jul;11(7):1702-13.